Solid lipid nanoparticles (SLNs) have been extensively studied as a strategy for overcoming the major challenges associated with oral drug delivery in recen
Recently, a major challenge in nanomedicine for cancer drug delivery is to engineer nanostructures which can efficiently load drugs with high concentration,
Repeated intravenous injection of PEGylated nanocarriers , such as PEGylated emulsions (PE) ,PEGylated nanoparticles, PEGylated micelles, and PEGylated lipo
Nanoparticle-based drug delivery has emerged as an effective strategy for pharmaceutical formulation and gained particular attention in biomedical field.Nan